ApaTech hires three senior executives
This article was originally published in Clinica
Executive Summary
Orthobiologics company ApaTech (Hertfordshire, UK) has appointed Jill Schiaparelli vice-president of commercial strategy and business development (global) and Melanie Marshall is named vice-president for clinical operations — both will join the company’s senior management team. And Todd Clearwater joins the US office as vice-president for national sales. Ms Schiaparelli joins from Johnson & Johnson, where she held a number of global strategy and marketing positions; Ms Marshall joins from Boston Scientific, where she was responsible for clinical strategy and execution across several divisions; and Mr Clearwater was most recently senior vice-president of sales at Interventional Spine. ApaTech specialises in developing and manufacturing synthetic bone repair material.
You may also be interested in...
Asia Regulatory Forum Update
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia adopts interim device authorisation regulation
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
Canada takes action to increase more adverse event reporting
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.